115 related articles for article (PubMed ID: 1359163)
1. Immunodeficiency and the risk of death in HIV infection.
Phillips AN; Elford J; Sabin C; Bofill M; Janossy G; Lee CA
JAMA; 1992 Nov; 268(19):2662-6. PubMed ID: 1359163
[TBL] [Abstract][Full Text] [Related]
2. Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection.
Phillips AN; Sabin CA; Elford J; Bofill M; Janossy G; Lee CA
BMJ; 1994 Jul; 309(6950):309-13. PubMed ID: 7916226
[TBL] [Abstract][Full Text] [Related]
3. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up.
Phillips AN; Sabin CA; Elford J; Bofill M; Lee CA; Janossy G
AIDS; 1993 Jul; 7(7):975-80. PubMed ID: 8102854
[TBL] [Abstract][Full Text] [Related]
4. CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy.
Yarchoan R; Venzon DJ; Pluda JM; Lietzau J; Wyvill KM; Tsiatis AA; Steinberg SM; Broder S
Ann Intern Med; 1991 Aug; 115(3):184-9. PubMed ID: 1676252
[TBL] [Abstract][Full Text] [Related]
5. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men.
Burack JH; Barrett DC; Stall RD; Chesney MA; Ekstrand ML; Coates TJ
JAMA; 1993 Dec; 270(21):2568-73. PubMed ID: 7901433
[TBL] [Abstract][Full Text] [Related]
6. CD4 lymphocyte count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian Seroconversion Study.
Phillips AN; Pezzotti P; Lepri AC; Rezza G
AIDS; 1994 Sep; 8(9):1299-305. PubMed ID: 7802984
[TBL] [Abstract][Full Text] [Related]
7. Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion.
Touloumi G; Karafoulidou A; Gialeraki A; Katsarou O; Milona I; Kapsimali V; Mandalaki T; Hatzakis A
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):89-97. PubMed ID: 9732075
[TBL] [Abstract][Full Text] [Related]
8. Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected persons.
Blatt SP; Lucey CR; Butzin CA; Hendrix CW; Lucey DR
JAMA; 1993 Feb; 269(5):622-6. PubMed ID: 8093628
[TBL] [Abstract][Full Text] [Related]
9. Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.
Cooper DA; Gatell JM; Kroon S; Clumeck N; Millard J; Goebel FD; Bruun JN; Stingl G; Melville RL; González-Lahoz J
N Engl J Med; 1993 Jul; 329(5):297-303. PubMed ID: 8100611
[TBL] [Abstract][Full Text] [Related]
10. CD8+ lymphocyte counts and the risk of death in advanced HIV infection.
Schlumpberger JM; Wolde-Tsadik G; Yao JF; Hara J
J Fam Pract; 1994 Jan; 38(1):33-8. PubMed ID: 8289049
[TBL] [Abstract][Full Text] [Related]
11. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
Margolick JB; Muñoz A; Vlahov D; Solomon L; Astemborski J; Cohn S; Nelson KE
JAMA; 1992 Mar; 267(12):1631-6. PubMed ID: 1347321
[TBL] [Abstract][Full Text] [Related]
12. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
13. The effects on survival of early treatment of human immunodeficiency virus infection.
Graham NM; Zeger SL; Park LP; Vermund SH; Detels R; Rinaldo CR; Phair JP
N Engl J Med; 1992 Apr; 326(16):1037-42. PubMed ID: 1347907
[TBL] [Abstract][Full Text] [Related]
14. Acquired immunodeficiency syndrome (AIDS) risk in recent and long-standing human immunodeficiency virus type 1 (HIV-1)-infected patients with similar CD4 lymphocyte counts.
Phillips AN; Sabin CA; Elford J; Bofill M; Janossy G; Lee CA
Am J Epidemiol; 1993 Nov; 138(10):870-8. PubMed ID: 7901990
[TBL] [Abstract][Full Text] [Related]
15. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
Moore RD; Keruly J; Richman DD; Creagh-Kirk T; Chaisson RE
AIDS; 1992 Jul; 6(7):671-7. PubMed ID: 1503686
[TBL] [Abstract][Full Text] [Related]
16. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study.
Cozzi Lepri A; Pezzotti P; Dorrucci M; Phillips AN; Rezza G
BMJ; 1994 Dec; 309(6968):1537-42. PubMed ID: 7819892
[TBL] [Abstract][Full Text] [Related]
17. Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.
Lee CA; Phillips AN; Elford J; Janossy G; Griffiths P; Kernoff P
BMJ; 1991 Nov; 303(6810):1093-6. PubMed ID: 1781870
[TBL] [Abstract][Full Text] [Related]
18. Relationship of CD4 lymphocyte counts to survival in a cohort of hemophiliacs infected with HIV. Multicenter Hemophilia Cohort Study.
Ehmann WC; Eyster ME; Wilson SE; Andes WA; Goedert JJ
J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1095-8. PubMed ID: 7916052
[TBL] [Abstract][Full Text] [Related]
19. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.
Volberding PA; Lagakos SW; Grimes JM; Stein DS; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS; Phair JP; Mitsuyasu RT
JAMA; 1994 Aug; 272(6):437-42. PubMed ID: 7913730
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of disease in persons with human immunodeficiency virus infection in the United States.
Farizo KM; Buehler JW; Chamberland ME; Whyte BM; Froelicher ES; Hopkins SG; Reed CM; Mokotoff ED; Cohn DL; Troxler S
JAMA; 1992 Apr; 267(13):1798-805. PubMed ID: 1347573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
